SOHM India to Boost Generic Pharmaceutical Product Line as Blockbuster Drugs Lose Patent Protection
BUENA PARK, CA–(Marketwire – 10/25/10) – SOHM, Inc. (Pinksheets: SHMN – News ), a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories announced today its India based pharmaceutical manufacturing facility sees a boost in its generic drug line as blockbuster drugs lose patent protection. Branded products, many of them first-line …
Read more on Marketwire via Yahoo! Finance
Former Chief Scientific Officer of Warner-Lambert and President of Parke-Davis Pharmaceutical Research Joins Aastrom …
ANN ARBOR, Mich. — Aastrom Biosciences, Inc. , a leading developer of expanded autologous cellular therapies for the treatment of severe cardiovascular diseases, today announced that Ronald Cresswell, Ph.D., Hon. D.Sc., FRSE, has joined the company’s board of directors.
Read more on GlobeNewswire via Yahoo! Finance
